Weiss Multi-Strategy Advisers’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,476	Closed	-$350K	–	832
2021 Q2	$350K	Sell	2,476 -276	-10%	-$31.2K	0.01%	585
2021 Q1	$274K	Sell	2,752 -114	-4%	-$13.3K	0.01%	608
2020 Q4	$354K	Sell	2,866 -15,134	-84%	-$1.99M	0.01%	612
2020 Q3	$1.75M	Buy	18,000 +3,046	+20%	+$381K	0.05%	367
2020 Q2	$2.33M	Buy	14,954 +542	+4%	+$82.4K	0.07%	310
2020 Q1	$2.08M	Buy	14,412 +4,124	+40%	+$796K	0.08%	249
2019 Q4	$2.1M	Buy	10,288 +7,288	+243%	+$1.33M	0.03%	417
2019 Q3	$241K	Buy	+3,000	New	+$255K	﹤0.01%	538

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RETA Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2021, closing a stake of 2,476 shares — an estimated $350K sold.

Weiss Multi-Strategy Advisers first reported a position in RETA in Q3 2019 and held it in 8 quarters. The position peaked at $2.33M in Q2 2020. 181 funds tracked by Wall St. Rank hold RETA as of Q3 2021.

Weiss Multi-Strategy Advisers reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 2,476 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2021, an estimated $350K.
Weiss Multi-Strategy Advisers first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2019 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $2.33M in Q2 2020.
181 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.